Correction of previously announced press release Sedana Medical AB (publ), Interim report Q2, 2018
In the press release published 30 August 07:00 CET the following has been reported: · EBITDA amounted to 1 794 (1 081) KSEK and the EBITDA margin was -6,0% (5,6%). Correct reporting is: · EBITDA amounted to -1 794 (1 081) KSEK and the EBITDA margin was -6,0% (5,6%). Below is the corrected press release in full.Sedana Medical AB (publ), Interim report Q2, 2018 The registration process for the United States commenced and European study resumed at full speed Financial Summary April-June · Net sales during the third quarter amounted to 14 485 (9 549) KSEK